WGS
GeneDx Holdings Corp.
+4.28 (+4.39%)101.70USD264K成交股數3.0B市值–本益比(近四季)6.7股價營收比+11.4%營收年增(近四季)2026-10-27下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 114M+11% | 102M+17% | 121M+57% | 117M+66% | 103M+65% | 87.1M+52% | 76.9M+44% | 70.5M+45% | 62.4M | 57.4M | 53.3M | 48.7M |
| 營業成本 | 36.2M | 34.0M | 36.7M | 32.2M | 31.8M | 28.6M | 29.0M | 27.6M | 25.0M | 26.7M | 28.0M | 29.9M |
| 毛利 | 78.2M+10% | 68.2M+17% | 84.3M+76% | 84.5M+97% | 70.9M+90% | 58.5M+90% | 47.8M+89% | 43.0M+129% | 37.4M | 30.8M | 25.3M | 18.8M |
| 毛利率 | 68.4% | 66.7% | 69.6% | 72.4% | 69.0% | 67.1% | 62.2% | 60.9% | 59.9% | 53.6% | 47.4% | 38.5% |
| 研發費用 | 19.7M | 19.8M | 24.5M | 19.8M | 15.1M | 12.6M | 11.7M | 10.9M | 11.6M | 12.2M | 14.3M | 17.1M |
| 銷售管理費用 | 76.0M | 74.6M | 9.1M | 44.4M | 46.9M | 50.5M | 26.9M | 26.0M | 23.4M | 31.9M | 26.1M | 37.3M |
| 營業利益 | −17.5M-295% | −57.5M+1163% | −14.2M+83% | −3.3M-69% | 9.0M-166% | −4.6M-82% | −7.8M-82% | −10.6M-80% | −13.7M | −25.6M | −43.0M | −51.6M |
| 營業利益率 | -15.3% | -56.2% | -11.8% | -2.8% | 8.7% | -5.2% | -10.1% | -15.0% | -21.9% | -44.7% | -80.6% | -106.0% |
| 稅後淨利 | −17.7M-264% | −63.3M+870% | −17.6M+112% | −7.6M-74% | 10.8M-153% | −6.5M-75% | −8.3M-80% | −29.2M-38% | −20.2M | −25.8M | −42.3M | −46.7M |
| 淨利率 | -15.5% | -61.9% | -14.6% | -6.5% | 10.5% | -7.5% | -10.8% | -41.4% | -32.4% | -44.9% | -79.3% | -95.9% |
| 稀釋 EPS | -0.60-267% | -2.16+839% | -0.59+90% | -0.27-75% | 0.36-146% | -0.23-68% | -0.31-81% | -1.10-40% | -0.78 | -0.71 | -1.64 | -1.84 |
| 稀釋股數 | 29.7M | 29.3M | 28.6M | 28.8M | 29.8M | 28.1M | 27.1M | 26.6M | 26.1M | 24.3M | 25.8M | 25.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 60.3M | 93.9M | 105M | 96.0M | 74.1M | 99.7M | 57.9M | 56.1M | 83.7M | 99.7M | 87.4M | 157M |
| 應收帳款 | 83.6M | 76.9M | 74.4M | 60.9M | 48.0M | 46.0M | – | – | – | – | – | – |
| 存貨 | 17.8M | 12.2M | 14.0M | 10.6M | 11.9M | 12.7M | 10.8M | 10.3M | 11.6M | 8.8M | 9.3M | 11.5M |
| 總資產 | 481M | 506M | 524M | 494M | 464M | 446M | 409M | 389M | 395M | 419M | 417M | 476M |
| 有息負債 | 96.8M | 96.7M | 48.2M | 51.6M | 51.7M | 51.8M | 52.0M | 52.2M | 52.3M | 52.7M | 6.1M | 6.3M |
| 總負債 | 237M | 252M | 216M | 202M | 187M | 189M | 204M | 195M | 187M | 191M | 163M | 180M |
| 股東權益 | 244M | 254M | 308M | 292M | 277M | 257M | 205M | 194M | 207M | 228M | 254M | 296M |
| 負債比 | 49.3% | 49.8% | 41.2% | 40.8% | 40.3% | 42.3% | 50.0% | 50.1% | 47.5% | 45.5% | 39.1% | 37.8% |
| 淨現金(現金 − 有息負債) | −36.5M | −2.8M | 56.8M | 44.4M | 22.4M | 47.9M | 5.9M | 3.9M | 31.4M | 47.0M | 81.3M | 150M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −32.4M-418% | – | – | – | 10.2M | – | – | −16.4M | – | – | – |
| 資本支出 | – | 6.5M | – | – | – | 6.1M | – | – | 443K | – | – | – |
| 自由現金流 | – | −38.9M-1059% | – | – | – | 4.1M | – | – | −16.9M | – | – | – |
| 折舊攤銷 | 3.1M | 2.7M | 2.7M | 2.4M | 2.3M | 2.2M | 2.4M | 1.7M | 1.7M | 2.6M | 5.2M | 6.8M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -38.0% | – | – | – | 4.7% | – | – | -27.0% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 428M
| Gene Dx | 423M | 99.0% | +40.0% |
|---|---|---|---|
| All Other Segments | 4.5M | 1.0% | +41.0% |
產品／服務2025 年度 · 428M
| Diagnostic Test Third Party Insurance | 345M | 80.7% | +47.1% |
|---|---|---|---|
| Diagnostic Test Institutional Customers | 70.1M | 16.4% | +7.6% |
| Product And Service Other | 10.9M | 2.5% | +230.1% |
| Diagnostic Test Self Pay | 1.4M | 0.3% | -41.9% |
| Diagnostic Test 小計 | 417M | 97.5% | +37.9% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 428M | +40.0% | −21.0M | -4.9% | -0.73 | 14.3M |
| FY2024 | 305M | +50.8% | −52.3M | -17.1% | -1.94 | −34.0M |
| FY2023 | 203M | -13.7% | −176M | -86.8% | -7.23 | −185M |
| FY2022 | 235M | +10.6% | −549M | -233.9% | -53.63 | −326M |
| FY2021 | 212M | +18.3% | −245M | -115.6% | -2.27 | −200M |
| FY2020 | 179M | -8.6% | −241M | -134.6% | -47036.00 | −117M |
| FY2019 | 196M | – | −29.7M | -15.1% | -264056.00 | −30.7M |